Neisseria gonorrheoae is the causative agent of gonorrhea, a sexually transmitted infection
responsible for a major burden of disease with a high global prevalence. Protective …

The intimate relationship between humans and Neisseria gonorrhoeae infections span
centuries, which is evidenced in case reports from studies dating back to the late 1700s and …

The concept of immunizing against gonorrhea has received renewed interest because of the
recent emergence of strains of Neisseria gonorrhoeae that are resistant to most currently …

Gonorrhoea continues to seriously impact human society with an estimated 106 million new
infections occurring annually. The consequence of gonorrhoea on reproductive and …

Gonorrhea occurs at high incidence throughout the world and significantly impacts
reproductive health and the spread of human immunodeficiency virus. Current control …

Gonorrhea is a major, global public health problem for which there is no vaccine. The
continuing emergence of antibiotic-resistant strains raises concerns that untreatable …

As antibiotic resistance continues to increase, vaccine development for N. gonorrhoeae
becomes more urgent. The MeNZB vaccine is shown to have efficacy, albeit relatively low …

Gonorrhea rates and antibiotic resistance are both increasing. Neisseria gonorrhoeae (Ng)
is an exclusively human pathogen and is exquisitely adapted to its natural host. Ng can …

Neisseria gonorrhoeae infection is an important public health issue, with an annual global
incidence of 87 million. N. gonorrhoeae infection causes significant morbidity and can have …

It is well-known that gonorrhea can be acquired repeatedly with no apparent development of
protective immunity arising from previous episodes of infection. Symptomatic infection is …